The effectiveness of chronic pelvic pain treatment in patients with endometriosis depending on the estrogen metabolite levels

The effectiveness of chronic pelvic pain treatment in patients with endometriosis depending on the estrogen metabolite levels

This article presents the results of studies 58 patients, mean age 29±1,7 years with chronic pelvic pain and laparoscopically confirmed diagnosis of external genital endometriosis. Based on the research results of estrogen metabolites has been allocated two groups studied patients. Group I – 26 pati...

Full description

Bibliographic Details
Main Authors: I B Manukhin, M V Prohorova, M A Gevorkyan, E I Manukhina, S O Smirnova
Format: Article
Language:Russian
Published: IP Berlin A.V. 2013-08-01
Series:Гинекология
Subjects:
pelvic pain
endometriosis
laparoscopy
estrogen metabolites
suppressive therapy
dienogest
Online Access:https://gynecology.orscience.ru/2079-5831/article/view/28218
Description
Summary:This article presents the results of studies 58 patients, mean age 29±1,7 years with chronic pelvic pain and laparoscopically confirmed diagnosis of external genital endometriosis. Based on the research results of estrogen metabolites has been allocated two groups studied patients. Group I – 26 patients (44,8%) with a predominance of carcinogenic fractions of estrogen in the urine of 2-ONE1/16-ONE1 least 2 (average 0,8±0,2), II group – 54 patients (55,2%) with normal estrоgen metabolism (average 2,3±0,3). Against the background of suppressive therapy with dienogest 2 mg after surgery in 12 months was significant (p
ISSN:2079-5696
2079-5831

Similar Items